BIOVIC B — Biovica International AB Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall CapNeutral
- SEK988.55m
- SEK912.00m
- SEK2.05m
Annual cashflow statement for Biovica International AB, fiscal year end - April 30th, SEK millions except per share, conversion factor applied.
R2018 April 30th | 2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18 | -21.5 | -30.3 | -39.4 | -60.1 |
| Depreciation | |||||
| Non-Cash Items | 0.292 | 0.373 | -0.349 | 0.146 | 0.052 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.097 | 0.165 | 1.66 | -1.31 | 1.48 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14.9 | -18 | -24.8 | -34.4 | -52.1 |
| Capital Expenditures | -8.59 | -7.33 | -7.04 | -3.56 | -3.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.126 | 0 | 0 | — | — |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8.46 | -7.33 | -7.04 | -3.56 | -3.4 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0 | 55.7 | 143 | -0.136 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -23.3 | -25.3 | 23.9 | 105 | -55.6 |